Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.In order to support governments and health authorities around the world to respond to the outbreak of global flu, British pharmaceutical giant GlaxoSmithKline has offered 50 million doses of pandemic vaccine to the World Health Organization (WHO).
Subscribe to our email newsletter
The company took this step in response to an appeal made by the UN and WHO to drug makers to save some of their pandemic vaccines for poor nations. The offer was made during a meeting between the UN officials, vaccine makers and other health experts. In addition, Glaxo will reduce its pandemic vaccine prices for developing nations.
Glaxo has received orders from several countries to stockpile pandemic flu vaccine. But it will start making the vaccine as soon as it gets the vaccine’s key ingredient, a “seed stock” based on the virus.